{
    "organizations": [],
    "uuid": "c6a11ac782bbed8b8b91ad503a53c3d49cbdbf97",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oxford-immunotec-announces-prelimi/brief-oxford-immunotec-announces-preliminary-revenue-for-q4-idUSASB0C04A",
    "ord_in_thread": 0,
    "title": "BRIEF-Oxford Immunotec Announces Preliminary Revenue For Q4",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Oxford Immunotec Global Plc:\n* FY2017 REVENUE VIEW $104.1 MILLION -- THOMSON REUTERS I/B/E/S\n* OXFORD IMMUNOTEC ANNOUNCES PRELIMINARY REVENUE FOR FOURTH QUARTER AND FULL YEAR 2017\n* SEES FY 2017 REVENUE $103 MILLION TO $103.5 MILLION * SEES Q4 2017 REVENUE $24.9 MILLION TO $25.4 MILLION * Q4 REVENUE VIEW $26.1 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-08T21:38:00.000+02:00",
    "crawled": "2018-01-09T17:11:23.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "oxford",
        "immunotec",
        "global",
        "plc",
        "fy2017",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "oxford",
        "immunotec",
        "announces",
        "preliminary",
        "revenue",
        "fourth",
        "quarter",
        "full",
        "year",
        "see",
        "fy",
        "revenue",
        "million",
        "million",
        "see",
        "q4",
        "revenue",
        "million",
        "million",
        "q4",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}